The latest study of the Faculty of Medicine, the University of Hong Kong, showed that the infection rate of a broad spectrum of drug-resistant superbugs, carbapenemase-producing enterobacteriaceae (CPE), keeps on increasing. The number of cases has reached over 1,000 since 2014.
The infection rate of CPE in high-risk patients increased nearly 40-fold from 2015 to 2019. The risk of infection for those that have taken beta-lactam antibiotics is increased by 37 percent.





